Clinical trialPhase 1Completed
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Regimens in Metastatic Pancreatic Ductal Adenocarcinoma Patients
- Outcome
- Finished, no results posted
- Phase
- Phase 1
- Status
- Completed
- Study type
- Interventional
- Start
- December 2013
- Expected end
- June 2021
- Enrollment
- 13 participants
- Sites
- 1
- Primary outcomes
- The Number of Participants with SAEs and AEs.
- Sponsor
- Other
- Results posted
- No
- Last update
- 18 February 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 3
- BackgroundHospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481207800243↗
- BackgroundCD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. DOI 10.1126/science.1198443↗
- BackgroundIntratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin pr… DOI 10.1084/jem.20101876↗